AU7303301A - Isolated nucleic acid molecules which encode t cell inducible factors, or interleukin-21, the proteins encoded, and uses thereof - Google Patents
Isolated nucleic acid molecules which encode t cell inducible factors, or interleukin-21, the proteins encoded, and uses thereofInfo
- Publication number
- AU7303301A AU7303301A AU7303301A AU7303301A AU7303301A AU 7303301 A AU7303301 A AU 7303301A AU 7303301 A AU7303301 A AU 7303301A AU 7303301 A AU7303301 A AU 7303301A AU 7303301 A AU7303301 A AU 7303301A
- Authority
- AU
- Australia
- Prior art keywords
- nucleic acid
- molecules
- acid molecules
- interleukin
- encode
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 102000039446 nucleic acids Human genes 0.000 title abstract 4
- 108020004707 nucleic acids Proteins 0.000 title abstract 4
- 150000007523 nucleic acids Chemical class 0.000 title abstract 4
- 102000004169 proteins and genes Human genes 0.000 title abstract 3
- 108090000623 proteins and genes Proteins 0.000 title abstract 3
- 230000001939 inductive effect Effects 0.000 title abstract 2
- 102100030704 Interleukin-21 Human genes 0.000 title 1
- 108010074108 interleukin-21 Proteins 0.000 title 1
- 102000011767 Acute-Phase Proteins Human genes 0.000 abstract 1
- 108010062271 Acute-Phase Proteins Proteins 0.000 abstract 1
- 102000004127 Cytokines Human genes 0.000 abstract 1
- 108090000695 Cytokines Proteins 0.000 abstract 1
- 206010061218 Inflammation Diseases 0.000 abstract 1
- 102000000585 Interleukin-9 Human genes 0.000 abstract 1
- 108010002335 Interleukin-9 Proteins 0.000 abstract 1
- 210000001744 T-lymphocyte Anatomy 0.000 abstract 1
- 230000004913 activation Effects 0.000 abstract 1
- 125000003275 alpha amino acid group Chemical group 0.000 abstract 1
- 230000004054 inflammatory process Effects 0.000 abstract 1
- 229940118526 interleukin-9 Drugs 0.000 abstract 1
- 238000002955 isolation Methods 0.000 abstract 1
- 230000001105 regulatory effect Effects 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
- G01N33/6869—Interleukin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/54—Interleukins [IL]
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
- G01N33/5047—Cells of the immune system
- G01N33/505—Cells of the immune system involving T-cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Cell Biology (AREA)
- Diabetes (AREA)
- Urology & Nephrology (AREA)
- Biochemistry (AREA)
- Pulmonology (AREA)
- Food Science & Technology (AREA)
- Biotechnology (AREA)
- Endocrinology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Toxicology (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Communicable Diseases (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Oncology (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US62661700A | 2000-07-27 | 2000-07-27 | |
| PCT/US2001/020485 WO2002010393A2 (en) | 2000-07-27 | 2001-06-27 | Isolated nucleic acid molecules which encode t cell inducible factors, or interleukin-21, the proteins encoded, and uses thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU7303301A true AU7303301A (en) | 2002-02-13 |
Family
ID=24511131
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU7303301A Withdrawn AU7303301A (en) | 2000-07-27 | 2001-06-27 | Isolated nucleic acid molecules which encode t cell inducible factors, or interleukin-21, the proteins encoded, and uses thereof |
Country Status (9)
| Country | Link |
|---|---|
| EP (2) | EP1806404B1 (enExample) |
| JP (1) | JP4113773B2 (enExample) |
| CN (3) | CN100497628C (enExample) |
| AT (2) | ATE478148T1 (enExample) |
| AU (1) | AU7303301A (enExample) |
| CA (1) | CA2416820A1 (enExample) |
| DE (2) | DE60142861D1 (enExample) |
| ES (1) | ES2349312T3 (enExample) |
| WO (1) | WO2002010393A2 (enExample) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7307161B1 (en) | 1999-04-28 | 2007-12-11 | Genetics Institute, Llc | Human Gil-19/AE289 polynucleotides |
| US6939545B2 (en) | 1999-04-28 | 2005-09-06 | Genetics Institute, Llc | Composition and method for treating inflammatory disorders |
| US20030170823A1 (en) | 1999-12-23 | 2003-09-11 | Presnell Scott R. | Novel cytokine ZCYTO18 |
| US20030012788A1 (en) | 2000-07-27 | 2003-01-16 | Jean-Christophe Renauld | Method for influencing kinase pathways with IL-22 |
| US20030023033A1 (en) * | 2001-07-26 | 2003-01-30 | Laure Dumoutier | Novel class II cytokine receptors and uses thereof |
| ES2277947T3 (es) * | 2000-10-13 | 2007-08-01 | Eli Lilly And Company | Procedimientos de uso de un polipeptido afin a il-17 humana para tratar enfermedades. |
| US7638604B2 (en) | 2001-02-23 | 2009-12-29 | Genetics Institute, Llc | Monoclonal antibodies against interleukin-22 |
| WO2003083062A2 (en) | 2002-03-22 | 2003-10-09 | Zymogenetics, Inc. | Anti-il-tif antibodies and methods of using in inflammation |
| AU2003251633A1 (en) | 2002-07-01 | 2004-01-19 | The Government Of The United States Of America As Represented By The Secretary Of The Department Of | Il-21 as a regulator of immunoglobin production |
| CA2497661A1 (en) * | 2002-09-11 | 2004-03-25 | Genentech, Inc. | Compositions and methods for the diagnosis of immune related diseases using pro71061 |
| US20060177421A1 (en) * | 2002-10-11 | 2006-08-10 | Novo Nordisk A/S | Treatment of allergic conditions by use of il 21 |
| EP1553970A1 (en) * | 2002-10-11 | 2005-07-20 | Novo Nordisk A/S | Treatment of allergic conditions by use of il 21 |
| ATE490275T1 (de) * | 2003-06-23 | 2010-12-15 | Genetics Inst Llc | Antikörper gegen interleukin-22 und verwendungen dafür |
| EP3006466B1 (en) | 2005-12-02 | 2018-08-01 | Genentech, Inc. | Compositions and methods for the treatment of diseases and disorders associated with cytokine signaling involving antibodies that bind to il-22 and il-22r |
| TWI417301B (zh) | 2006-02-21 | 2013-12-01 | Wyeth Corp | 對抗人類介白素-２２（ｉｌ-２２）之抗體及其用途 |
| TW200744634A (en) | 2006-02-21 | 2007-12-16 | Wyeth Corp | Methods of using antibodies against human IL-22 |
| IT1404858B1 (it) | 2011-02-21 | 2013-12-09 | Milano Politecnico | Supporto anti-sismico. |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5843697A (en) | 1996-07-17 | 1998-12-01 | University Of Medicine And Dentistry Of New Jersey | Cells expressing IL-10 receptor and the CRFB4 gene product, an IL-10 receptor accessory protein |
| DE19848683B4 (de) | 1998-10-22 | 2004-05-06 | Basf Ag | Verbundschichtplatte |
| JP3769189B2 (ja) * | 1998-10-26 | 2006-04-19 | ルードヴィッヒ インスティテュート フォー キャンサー リサーチ | Ｔ細胞誘導性因子（ｔｉｆ）をコードする単離された核酸分子、コードされたタンパク質およびその使用 |
| EP1177312B1 (en) * | 1999-04-28 | 2007-10-31 | Genetics Institute, LLC | Human gil-19/ae289 proteins and polynucleotides encoding same |
| WO2000073457A1 (en) * | 1999-05-27 | 2000-12-07 | Schering-Corporation | Mammalian interleukin-10 homologs: il-d110 and il-d210 |
| CA2393369A1 (en) * | 1999-12-03 | 2001-06-07 | Zymogenetics, Inc. | Human cytokine receptor |
-
2001
- 2001-06-27 AT AT07002409T patent/ATE478148T1/de not_active IP Right Cessation
- 2001-06-27 CN CNB2005101169978A patent/CN100497628C/zh not_active Expired - Fee Related
- 2001-06-27 CN CNB018131255A patent/CN100448994C/zh not_active Expired - Fee Related
- 2001-06-27 EP EP07002409A patent/EP1806404B1/en not_active Expired - Lifetime
- 2001-06-27 AU AU7303301A patent/AU7303301A/xx not_active Withdrawn
- 2001-06-27 AT AT01952260T patent/ATE365801T1/de not_active IP Right Cessation
- 2001-06-27 JP JP2002516309A patent/JP4113773B2/ja not_active Expired - Fee Related
- 2001-06-27 EP EP01952260A patent/EP1305419B1/en not_active Expired - Lifetime
- 2001-06-27 DE DE60142861T patent/DE60142861D1/de not_active Expired - Lifetime
- 2001-06-27 ES ES07002409T patent/ES2349312T3/es not_active Expired - Lifetime
- 2001-06-27 CA CA002416820A patent/CA2416820A1/en not_active Abandoned
- 2001-06-27 DE DE60129137T patent/DE60129137D1/de not_active Expired - Lifetime
- 2001-06-27 CN CNA2008101764854A patent/CN101423551A/zh active Pending
- 2001-06-27 WO PCT/US2001/020485 patent/WO2002010393A2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| JP2004504842A (ja) | 2004-02-19 |
| WO2002010393A2 (en) | 2002-02-07 |
| CA2416820A1 (en) | 2002-02-07 |
| WO2002010393A3 (en) | 2003-01-30 |
| CN100448994C (zh) | 2009-01-07 |
| EP1305419B1 (en) | 2007-06-27 |
| CN101423551A (zh) | 2009-05-06 |
| JP4113773B2 (ja) | 2008-07-09 |
| CN100497628C (zh) | 2009-06-10 |
| EP1305419A2 (en) | 2003-05-02 |
| CN1443241A (zh) | 2003-09-17 |
| ATE365801T1 (de) | 2007-07-15 |
| ATE478148T1 (de) | 2010-09-15 |
| CN1796558A (zh) | 2006-07-05 |
| EP1806404A1 (en) | 2007-07-11 |
| ES2349312T3 (es) | 2010-12-29 |
| DE60142861D1 (de) | 2010-09-30 |
| DE60129137D1 (de) | 2007-08-09 |
| EP1806404B1 (en) | 2010-08-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE469911T1 (de) | Isolierte nukleinsäuremoleküle die t-zellen induzierbare faktoren kodieren (tif), kodierte proteine und ihre anwendung | |
| AU7303301A (en) | Isolated nucleic acid molecules which encode t cell inducible factors, or interleukin-21, the proteins encoded, and uses thereof | |
| DE69833670D1 (de) | Homologe des tie-rezeptortyrosinekinase liganden | |
| TR200100056T2 (tr) | Nörotrofik faktörler | |
| DE69942861D1 (de) | Ldcam genannte moleküle | |
| PT765394E (pt) | Lacases myceliophthora purificadas e acidos nucleicos que as codificam | |
| ATE415480T1 (de) | B7l-1 moleküle | |
| ATE227739T1 (de) | Hybridprotein zur hemmung der mastzelldegranulation und dessen verwendung | |
| WO2002014485A3 (en) | Kallikrein gene | |
| DE60138715D1 (de) | Tnf-rezeptor-ähnliche moleküle und deren anwendungen | |
| DK1117798T3 (da) | Fungal transskriptionel aktivator egnet ved fremgangsmåder til produktion af polypeptider | |
| BR0312521A (pt) | Métodos para a separação e a purificação de fibrinogênio e de pelo menos uma outra proteìna e para a co-purificação de fibrinogênio e de fator xiii, uso de cromatografia de afinidade com ìon de metal imobilizado, fibrinogênio, kit farmacêutico, e, formulações farmacêutica e de fibrinogênio liofilizado | |
| WO2003050283A3 (en) | A structure for presenting desired peptide sequences | |
| DE60141588D1 (de) | Nukleinsäuresequenz und protein, das eine rolle bei der zellulären alterung spielt | |
| DK1387854T3 (da) | SFRP og peptidmotiver som interagerer med SFRP og fremgangsmåder til anvendelse deraf | |
| WO2001066752A3 (en) | Reproduction-specific genes | |
| WO2005000870A3 (en) | Isolated ny-eso-1 peptides which bind to hla class ii molecules and uses thereof | |
| DK1005532T3 (da) | Isolerede nukleinsyremolekyler kodende for SSX familiemedlemmer og anvendelser deraf | |
| DE69928668D1 (de) | Archivierung von vektoren | |
| ZA99445B (en) | Isolated, polypeptides which bind to HLA-A29 molecules nucleic acid, the molecules encoding these, and uses thereof. | |
| KR20040053279A (ko) | 스트레스 저항성 및 내성 단백질을 코딩하는 유전자 | |
| AU2001253804A1 (en) | Isolated human transporter proteins, nucleic acid molecules encoding the same, and uses thereof | |
| DE602004021922D1 (de) | Induktion der blütenbildung | |
| WO2004078776A3 (en) | Ny-eso-1 peptides which bind to class ii molecules and uses thereof | |
| SE0003099D0 (sv) | Adhesive protein and uses therefore |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FGA | Letters patent sealed or granted (standard patent) | ||
| MK14 | Patent ceased section 143(a) (annual fees not paid) or expired |